CliffBio
small molecule

CARVEDILOL PHOSPHATE

CARVEDILOL PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanySUN PHARMACEUTICAL INDUSTRIES INC

Drug detail

Brand nameCARVEDILOL PHOSPHATE
Active ingredientCARVEDILOL PHOSPHATE
Strength80MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2017
Marketing statusRX

More from SUN PHARMACEUTICAL INDUSTRIES INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CARVEDILOL PHOSPHATE patent cliff — loss of exclusivity — | CliffBio